As co-chairs of the Senate Diabetes Caucus, which I founded in 1998, Senator Jeanne Shaheen and I introduced legislation in the last Congress to create a new pricing model for insu...
Opening statement.
When a doctor prescribes a needed medication, an insurmountable barrier to taking it should not be its cost.
Let's bring this bill to the Senate floor as separate legislation so that we can have full and open debate and amendment...
How should Congress ensure that we are recognizing innovative science versus rewarding an innovative legal strategy that...
I think we're in the early innings of what will become an evolving set of tools that many innovator drug companies may e...
I led a bipartisan investigation with then-Senator Claire McCaskill of Missouri on sudden price spikes of off-patent dru...
Later this spring, along with my colleague Senator Tim Kaine, I will reintroduce the Biologic Patent Transparency Act to...
I also worked with Senator Bob Casey to investigate various entities in the opaque market for pricing of prescription dr...
Even though there are several biosimilars for the best-selling drug in the world, Humira, and they've been on the market...
I think this is an area that cries out for reform.